Groupe Francophone Des Myelodysplasies
Clinical trials sponsored by Groupe Francophone Des Myelodysplasies, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo tackles relapsed blood cancers after transplant Results expected Nov 2026 (estimated)
- Can a Gene-Targeted pill turn the tide against a rare blood cancer? Results expected Apr 2027 (estimated)